AbbVie (ABBV) News Today $220.09 +8.45 (+3.99%) Closing price 09/11/2025 03:59 PM EasternExtended Trading$220.22 +0.13 (+0.06%) As of 05:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is AbbVie Up Today?Toggle Visibility of Why Is AbbVie Up Today?AbbVie Inc. (NYSE: ABBV) shares climbed today after the company announced a series of developments that strengthen its long-term outlook, most notably securing extended patent protection for its flagship immunology drug, Rinvoq. Positive Sentiment: AbbVie secured extended U.S. patent protection for Rinvoq (upadacitinib) through settlements with generic manufacturers, delaying generic entry until April 2037. AbbVie shares hit record high as key immunology drug set for exclusivity until 2037 Positive Sentiment: The stock reached an all-time intraday high of $220.84 following the Rinvoq patent news. AbbVie stock reaches all-time high at 220.84 USD Positive Sentiment: William Blair reaffirmed a Buy rating on ABBV after the exclusivity extension, citing stronger long-term revenue visibility. AbbVie’s Rinvoq Franchise Secures Extended Exclusivity, Boosting Long-Term Prospects and Justifying Buy Rating Positive Sentiment: Benzinga and other outlets note the settlement delays U.S. competition for upadacitinib until at least 2037, reinforcing Rinvoq’s “cash cow” status. Why Is AbbVie Stock Trading Higher On Thursday? Neutral Sentiment: AbbVie updated investors on its Phase 1 ABBV-1088 anti-inflammatory study, detailing trial progress without immediate revenue impact. AbbVie’s ABBV-1088 Study: A Closer Look at Recent Developments Neutral Sentiment: A new U.S. cystic fibrosis therapeutics market report featuring AbbVie highlights competitive trends but offers no near-term catalyst. US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F ... Neutral Sentiment: Zacks.com flagged AbbVie as a trending stock based on search activity, indicating elevated investor interest but no new fundamental news. AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Posted 10h agoAI Generated. May Contain Errors. ABBV Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Acadian Asset Management LLC Has $29.90 Million Stock Position in AbbVie Inc. $ABBV1 hour ago | marketbeat.comThe Best Stocks to Invest $50,000 In Right Now2 hours ago | fool.comDynamic Technology Lab Private Ltd Invests $383,000 in AbbVie Inc. $ABBV3 hours ago | marketbeat.comAbbVie shares rise with extension of RINVOQ patent protection to 2037September 11 at 1:26 PM | proactiveinvestors.comAbbVie stock reaches all-time high at 220.84 USDSeptember 11 at 12:36 PM | investing.comAbbVie stock rises after securing patent protection for RINVOQ until 2037September 11 at 12:36 PM | finance.yahoo.comWhy AbbVie (ABBV) Stock Is Trading Up TodaySeptember 11 at 12:36 PM | msn.comAbbVie’s ABBV-1088 Study: A Closer Look at Recent DevelopmentsSeptember 11 at 12:31 PM | tipranks.comAbbVie shares hit record high as key immunology drug set for exclusivity until 2037September 11 at 12:25 PM | reuters.comAbbVie in Settlement With Generic Drugmakers on RinvoqSeptember 11 at 12:17 PM | wsj.comAbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another DaySeptember 11 at 12:10 PM | investors.comAbbVie’s Rinvoq Franchise Secures Extended Exclusivity, Boosting Long-Term Prospects and Justifying Buy RatingSeptember 11 at 11:10 AM | tipranks.com‘Really Long Runway’: AbbVie Stock (ABBV) Jumps afer Settlement on Anti-Inflammatory DrugSeptember 11 at 10:31 AM | tipranks.comWhy Is AbbVie Stock Trading Higher On Thursday?September 11 at 10:11 AM | benzinga.comAbbVie: What's Happening With ABBV Stock?September 11 at 10:05 AM | forbes.comMcAdam LLC Lowers Stake in AbbVie Inc. $ABBVSeptember 11 at 9:36 AM | marketbeat.comIFM Investors Pty Ltd Raises Position in AbbVie Inc. $ABBVSeptember 11 at 9:03 AM | marketbeat.comBlue Rock Wealth Management LLC Invests $285,000 in AbbVie Inc. $ABBVSeptember 11 at 9:02 AM | marketbeat.comFortis Capital Advisors LLC Cuts Position in AbbVie Inc. $ABBVSeptember 11 at 8:42 AM | marketbeat.comBelpointe Asset Management LLC Has $7.26 Million Stake in AbbVie Inc. $ABBVSeptember 11 at 8:41 AM | marketbeat.comAbbVie Settles to Delay RINVOQ Generics Until 2037September 11 at 8:30 AM | tipranks.comIntech Investment Management LLC Decreases Position in AbbVie Inc. $ABBVSeptember 11 at 8:19 AM | marketbeat.comFocus Partners Wealth Acquires 39,164 Shares of AbbVie Inc. $ABBVSeptember 11 at 8:18 AM | marketbeat.comIntegrity Alliance LLC. Has $4.78 Million Holdings in AbbVie Inc. $ABBVSeptember 11 at 7:58 AM | marketbeat.com13,215 Shares in AbbVie Inc. $ABBV Purchased by Ransom Advisory LtdSeptember 11 at 7:48 AM | marketbeat.comAnchor Investment Management LLC Sells 5,805 Shares of AbbVie Inc. $ABBVSeptember 11 at 7:48 AM | marketbeat.comGlenview Trust co Purchases 1,974 Shares of AbbVie Inc. $ABBVSeptember 11 at 7:47 AM | marketbeat.comPlato Investment Management Ltd Sells 13,721 Shares of AbbVie Inc. $ABBVSeptember 11 at 7:29 AM | marketbeat.comSCS Capital Management LLC Takes Position in AbbVie Inc. $ABBVSeptember 11 at 7:02 AM | marketbeat.comMBB Public Markets I LLC Acquires Shares of 1,501 AbbVie Inc. $ABBVSeptember 11 at 6:11 AM | marketbeat.comJones Financial Companies Lllp Sells 141,991 Shares of AbbVie Inc. $ABBVSeptember 11 at 3:59 AM | marketbeat.comUS Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F ...September 10 at 4:32 PM | finance.yahoo.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Boosts Holdings in AbbVie Inc. $ABBVSeptember 10 at 7:08 AM | marketbeat.comAbbVie Inc. $ABBV Shares Sold by DCM Advisors LLCSeptember 10 at 7:08 AM | marketbeat.comAbbVie Inc. $ABBV Shares Acquired by Woodline Partners LPSeptember 10 at 6:49 AM | marketbeat.comZurich Insurance Group Ltd FI Buys 170,629 Shares of AbbVie Inc. $ABBVSeptember 10 at 6:48 AM | marketbeat.comAmerican Trust Cuts Holdings in AbbVie Inc. $ABBVSeptember 10 at 6:18 AM | marketbeat.comEmpowered Funds LLC Increases Stock Position in AbbVie Inc. $ABBVSeptember 10 at 6:02 AM | marketbeat.comLogan Capital Management Inc. Purchases 4,465 Shares of AbbVie Inc. $ABBVSeptember 10 at 6:02 AM | marketbeat.comPeloton Wealth Strategists Reduces Holdings in AbbVie Inc. $ABBVSeptember 10 at 5:53 AM | marketbeat.comCaxton Associates LLP Makes New Investment in AbbVie Inc. $ABBVSeptember 10 at 5:36 AM | marketbeat.comCoppell Advisory Solutions LLC Raises Stock Holdings in AbbVie Inc. $ABBVSeptember 10 at 5:29 AM | marketbeat.comTrump announces crackdown on drug ads, a sign of trouble for big-spending AbbVieSeptember 9 at 8:27 PM | msn.comAbbVie (NYSE:ABBV) Shares Down 1% - Here's WhySeptember 9 at 3:56 PM | marketbeat.comAbbVie Inc. (ABBV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 9 at 2:13 PM | seekingalpha.comAscent Group LLC Sells 1,360 Shares of AbbVie Inc. $ABBVSeptember 9 at 8:32 AM | marketbeat.comAbbVie Inc. $ABBV Position Reduced by RNC Capital Management LLCSeptember 9 at 8:10 AM | marketbeat.comUnited Services Automobile Association Has $8.40 Million Holdings in AbbVie Inc. $ABBVSeptember 9 at 8:02 AM | marketbeat.comMeiji Yasuda Asset Management Co Ltd. Sells 31,981 Shares of AbbVie Inc. $ABBVSeptember 9 at 8:00 AM | marketbeat.comBOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive StoriesSeptember 9 at 8:00 AM | prnewswire.com Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABBV Media Mentions By Week ABBV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼1.121.01▲Average Medical News Sentiment ABBV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼9543▲ABBV Articles Average Week Get the Latest News and Ratings for ABBV and Related Stocks Enter your email address to receive the latest news and analysts' ratings for AbbVie and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AMGN News Today GILD News Today MRNA News Today ABT News Today BMY News Today JNJ News Today LLY News Today MRK News Today PFE News Today ZTS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
